Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Major Depressive Disorder (MDD) is increasingly linked to inflammatory processes.
• The innate immune system, particularly complement proteins, influences neurobiological functions.
• Limited research exists on the specific roles of complement proteins in MDD.

Purpose of the Study:

• To investigate the plasma levels of seven key complement proteins in individuals with MDD.
• To explore the association between complement protein levels and the clinical characteristics of MDD.
• To elucidate the potential involvement of the complement pathway in the pathophysiology of MDD.

Main Methods:

• Plasma samples from 22 MDD patients and 27 healthy controls were analyzed using a multiplex suspension assay.
• Seven complement proteins (C1q, C3, C3b/iC3b, C4, Factor B, Factor H, properdin) were quantified.
• Clinical assessments included DSM IV-TR diagnosis, HAM-D, and other scales; correlations with protein levels were examined.

Main Results:

• No significant differences in age or gender were observed between MDD patients and controls.
• MDD patients exhibited significantly elevated plasma levels of C1q, Factor B, and Factor H compared to healthy controls.
• No significant correlations were found between the plasma levels of these complement proteins and clinical MDD scores.

Conclusions:

• Elevated levels of C1q, Factor B, and Factor H suggest their involvement in MDD.
• Factor B and Factor H are critical for the alternative complement pathway, highlighting its role in inflammation.
• These findings point to the alternative complement pathway's significant contribution to immuno-inflammation in MDD.